graphic
abstract
highlight
bind
influenza
ribonucleoprotein
vrnp
nucleu
vrnp
act
clamp
inhibit
viral
rna
chain
elong
restrict
influenza
rna
synthesi
reconstitut
vitro
influenza
protein
antagon
antiinfluenza
activ
summari
ubiquitin
ligas
activ
rigi
promot
antivir
interferon
respons
protein
strain
influenza
viru
bind
although
viru
strain
block
interferon
respons
suggest
altern
mechan
action
present
nuclear
role
specif
restrict
influenza
viru
replic
inhibit
viral
rna
synthesi
direct
mechan
independ
ubiquitin
ligas
activ
interferon
pathway
activ
inhibit
viral
protein
inhibit
viral
rna
synthesi
result
bind
viral
ribonucleoprotein
vrnp
structur
contain
individu
viral
rna
segment
viral
polymeras
multipl
viral
nucleoprotein
bind
inhibit
initi
cappedrnaprim
viral
mrna
synthesi
viral
polymeras
rather
onset
rna
chain
elong
inhibit
prohibit
movement
rna
polymeras
complex
brief
meyerson
et
al
identifi
antiinfluenza
activ
nucleu
specif
target
influenza
viru
replic
bind
viralrnacontain
ribonucleoprotein
vrnp
bind
vrnp
nuclei
infect
cell
act
molecular
clamp
depriv
viral
polymeras
rna
templat
promot
interferon
respons
viru
infect
specif
activ
rigi
initi
signal
pathway
lead
activ
interferon
regulatori
factor
transcript
interferon
gene
gack
et
al
gack
et
al
ubiquitin
ligas
activ
rigi
ubiquitin
directli
andor
synthes
unanchor
polyubiquitin
chain
bind
rigi
gack
et
al
gack
et
al
zeng
et
al
influenza
virus
caus
annual
highli
contagi
respiratori
diseas
human
respons
pandem
result
high
mortal
rate
wright
et
al
influenza
viru
genom
compris
eight
segment
negativesens
viral
rna
smallest
segment
encod
protein
multifunct
nonstructur
protein
antagon
host
antivir
respons
regul
virushost
interact
krug
garciasastr
one
function
protein
bind
ligas
inhibit
multimer
thu
ligas
activ
action
postul
block
activ
rigi
pathway
gack
et
al
howev
humancircul
influenza
viru
strain
block
rigimedi
activ
interferonb
transcript
kuo
et
al
kuo
et
al
although
protein
test
strain
bind
gack
et
al
kuo
et
al
rajsbaum
et
al
notabl
strong
activ
interferonb
transcript
still
occur
cell
infect
virus
express
protein
humancircul
virus
kuo
et
al
kuo
et
al
consequ
bind
protein
directli
correl
suppress
interferonb
induct
cell
infect
influenza
viru
result
led
us
propos
protein
antagon
differ
unknown
function
present
studi
identifi
previous
unknown
function
inhibit
protein
demonstr
directli
restrict
influenza
viral
rna
synthesi
infect
cell
like
restrict
enzym
bacteria
mammalian
restrict
factor
block
viru
replic
directli
without
need
extens
cellular
signal
blancomelo
et
al
restrict
activ
independ
ubiquitin
ligas
activ
interferon
induct
pathway
fact
restrict
influenza
virus
direct
reconstitut
purifi
compon
vitro
show
inhibit
viral
rna
synthesi
result
bind
doublehel
influenza
viral
ribonucleoprotein
vrnp
complex
contain
individu
viral
rna
viral
rna
polymeras
multipl
viral
nucleoprotein
np
coat
viral
rna
arranz
et
al
resainfant
et
al
te
velthui
fodor
ye
et
al
show
bind
vrnp
vitro
assay
also
nucleu
virusinfect
cell
viral
rna
synthesi
take
place
herz
et
al
glycerol
gradient
analysi
electron
microscopi
em
reveal
bind
along
length
vrnp
rnadepend
manner
appar
preferenti
bind
site
vitro
transcript
assay
indic
bind
onto
vrnp
inhibit
initi
cappedrnaprim
viral
mrna
synthesi
vrnpassoci
polymeras
rather
inhibit
onset
rna
chain
elong
like
act
molecular
clamp
vrnpassoci
templat
rna
model
simultan
bind
rna
protein
compon
vrnp
lock
rna
place
block
movement
viral
polymeras
mutat
introduc
multifunct
protein
frequent
result
perturb
one
mani
function
krug
garciasastr
reason
took
two
altern
approach
obviat
antagon
could
studi
activ
suppress
first
approach
overexpress
level
exceed
amount
protein
produc
infect
cell
overexpress
use
retrovir
vector
gener
transgen
cell
line
stabli
express
either
flagtag
human
flagtag
three
differ
nonhuman
primat
speci
agil
gibbon
orangutan
talapoin
latter
repres
version
human
influenza
virus
expos
nonhuman
primat
protein
found
especi
potent
human
influenza
viru
one
gibbon
prove
crucial
determin
mechan
action
influenza
viru
found
cell
background
test
crfk
cell
support
stabl
highlevel
express
protein
figur
higher
level
endogen
human
express
human
cell
figur
crfk
cell
transduc
empti
vector
vector
express
restrict
factor
stremlau
et
al
creat
neg
control
compar
amount
human
nonhuman
primat
protein
stabli
produc
crfk
cell
line
express
doublet
upper
band
autoubiquitin
inn
et
al
demonstr
crfk
cell
line
infect
plaqueform
unit
pfu
per
cell
influenza
udorn
viru
viru
replic
monitor
determin
level
viral
protein
hr
postinfect
use
immunoblot
figur
cell
express
human
viral
protein
synthesi
reduc
udorninfect
cell
compar
neg
control
reduct
viral
protein
level
much
greater
cell
express
nonhuman
primat
molecul
exampl
viral
protein
level
cell
express
gibbon
reduc
udorninfect
cell
despit
fact
human
gibbon
differ
sequenc
amino
acid
posit
figur
similar
result
obtain
use
pandem
influenza
viru
figur
product
influenza
b
viru
protein
also
inhibit
human
gibbon
case
sendai
viru
panel
retrovirus
figur
indic
inhibit
direct
influenza
b
virus
inhibit
influenza
viru
protein
product
reliev
boost
protein
level
prior
infect
use
retroviru
express
protein
figur
protein
influenza
use
experi
protein
bind
would
effect
limit
amount
mrna
via
inhibit
end
process
polymeraseiidriven
premrna
krug
garciasastr
test
wildtyp
wt
mutant
protein
latter
bind
gack
et
al
wt
protein
led
increas
influenza
viru
protein
product
crfk
cell
express
human
wherea
level
mutant
protein
led
increas
viral
protein
product
cell
result
indic
protein
antagon
antivir
activ
excess
molecul
produc
crfk
cell
rel
control
crfk
cell
rate
viru
replic
inhibit
crfk
cell
express
human
crfk
cell
express
gibbon
figur
hr
infect
pfu
per
cell
use
quantit
rtpcr
measur
level
mrna
viral
rna
vrna
encod
three
viral
gene
np
ha
hemagglutinin
figur
level
virusspecif
rna
lower
crfk
cell
express
either
human
gibbon
compar
cell
transduc
empti
plasmid
gibbon
inhibit
virusspecif
rna
synthesi
effect
human
exampl
viral
mrna
level
reduc
crfk
cell
express
human
crfk
cell
express
gibbon
conclud
inhibit
influenza
viral
replic
infect
cell
step
viral
rna
synthesi
step
upstream
rna
synthesi
also
conclud
gibbon
potent
inhibitor
viral
replic
human
human
gibbon
similar
bind
affin
protein
figur
unlik
greater
inhibit
observ
gibbon
due
differenti
inhibit
protein
verifi
minigenom
assay
describ
second
approach
demonstr
endogen
human
cell
inhibit
influenza
replic
accordingli
delet
gene
human
cell
use
figur
ensur
effect
delet
simpli
manifest
fail
activ
interferon
respons
via
rigi
pathway
also
delet
rigi
gene
background
control
delet
line
thu
wt
cell
rigi
knockout
cell
doubl
rigi
knockout
cell
infect
pfu
per
cell
udorn
viru
viru
replic
monitor
determin
level
viral
protein
hr
postinfect
use
immunoblot
figur
level
viral
protein
product
cell
rigi
knock
lane
higher
level
cell
rigi
knock
lane
demonstr
endogen
inhibit
viral
protein
product
independ
rigi
pathway
ensur
effect
observ
stabli
complement
doubleknockout
cell
line
either
flagtag
version
human
gibbon
empti
vector
control
figur
import
note
stabl
overexpress
toler
doubleknockout
cell
wherea
wt
cell
presenc
human
influenza
protein
product
reduc
level
observ
wt
cell
figur
cell
line
express
gibbon
show
even
greater
reduct
viral
protein
product
line
experi
carri
crfk
cell
line
complement
experi
show
effect
observ
knockout
cell
specif
use
quantit
rtpcr
measur
level
sever
mrna
viral
rna
vrna
time
point
hr
infect
wt
cell
rigi
knockout
cell
rigi
doubleknockout
cell
figur
synthesi
viral
mrna
vrna
increas
doubleknockout
cell
rel
wt
rigi
knockout
cell
figur
account
inhibit
viral
protein
synthesi
quantit
immunoblot
perform
use
imagej
softwar
percent
reduct
viral
protein
level
rel
vector
control
shown
valu
percent
reduct
correspond
averag
chang
level
ha
np
viral
protein
band
normal
use
actin
control
c
crfk
cell
line
express
human
pretreat
indic
amount
wildtyp
wt
retroviru
mutant
retroviru
control
retroviru
ctl
cell
infect
pfu
per
cell
udorn
viru
cell
extract
collect
mock
infect
cell
immunoblot
use
rabbit
antibodi
refer
amount
present
time
infect
extract
cell
collect
hr
postinfect
immunoblot
use
antiudorn
polyclon
antibodi
quantit
immunoblot
perform
b
fold
rescu
rel
sampl
receiv
control
retroviru
report
data
present
b
c
repres
two
experiment
replic
express
normal
gapdh
mrna
level
error
bar
repres
standard
deviat
three
independ
experi
mrna
vrna
group
pass
oneway
anova
test
p
asterisk
indic
signific
p
pairwis
comparison
posthoc
tukeykram
test
see
also
figur
indic
inhibit
viral
protein
synthesi
due
either
inhibit
viral
rna
synthesi
step
upstream
rna
synthesi
consequ
increas
level
viral
rna
protein
synthesi
rate
viru
replic
doubleknockout
cell
increas
rel
viru
replic
wt
rigi
knockout
cell
figur
base
overexpress
knockout
result
conclud
block
influenza
viru
replic
within
cell
activ
rigi
interferon
induct
pathway
requir
ligas
activ
gack
et
al
zeng
et
al
determin
whether
also
case
antivir
activ
describ
accordingli
mutat
human
gibbon
critic
zinccoordin
cystein
ring
domain
reymond
et
al
abolish
ubiquitin
ligas
activ
figur
establish
stabl
crfk
cell
line
express
mutat
protein
shown
figur
bottom
mutat
elimin
autoubiquitin
impair
abil
inhibit
influenza
viru
replic
figur
upper
confirm
lack
ligas
activ
inhibit
viral
rna
synthesi
carri
minigenom
assay
measur
viral
rna
synthesi
influenza
viru
rna
synthesi
take
place
context
vrnp
influenza
vrnp
compris
one
rna
genom
segment
viral
polymeras
complex
compris
pa
protein
multipl
np
protein
coat
rna
genom
segment
arranz
et
al
resainfant
et
al
te
velthui
fodor
ye
et
al
minigenom
assay
cell
transfect
plasmid
express
protein
compon
vrnp
plasmid
express
neg
sens
firefli
luciferas
report
gene
flank
termin
region
influenza
vrna
report
gene
express
context
activ
influenza
polymeras
complex
plasmid
express
renilla
luciferas
cotransfect
along
plasmid
control
transfect
figur
error
bar
repres
standard
deviat
three
independ
experi
mrna
vrna
group
pass
oneway
anova
test
p
asterisk
indic
signific
p
pairwis
comparison
posthoc
tukeykram
test
ns
signific
time
cours
viru
replic
infect
indic
cell
pfu
per
cell
udorn
viru
error
bar
repres
standard
error
three
independ
experi
asterisk
indic
signific
oneway
anova
comparison
p
signific
time
point
posthoc
tukeykram
test
found
comparison
doubleknockout
cell
line
signific
p
comparison
wt
rigi
knockout
cell
line
signific
see
also
figur
effici
firefli
renilla
luciferas
ratio
measur
viral
rna
synthesi
determin
effect
viral
rna
synthesi
cotransfect
along
plasmid
increas
amount
plasmid
express
ligasedefici
human
gibbon
protein
total
elimin
rigi
pathway
analysi
engin
cell
via
disrupt
rigi
figur
shown
figur
human
gibbon
inhibit
influenza
rna
synthesi
assay
note
conduct
absenc
rigi
result
show
neither
ubiquitin
ligas
activ
interferon
signal
requir
inhibit
influenza
viru
rna
synthesi
observ
inhibit
viral
rna
synthesi
minigenom
assay
gibbon
human
revers
plasmid
encod
wt
protein
addit
transfect
figur
revers
inhibit
similar
gibbon
human
consist
observ
similar
bind
affin
protein
figur
contrast
inhibit
revers
plasmid
express
mutant
protein
bind
mirror
infect
cell
result
result
demonstr
protein
counteract
inhibit
influenza
viral
rna
synthesi
caus
ligasedefici
protein
inhibit
viral
rna
synthesi
minigenom
assay
indic
target
one
compon
influenza
vrnp
determin
whether
bind
vrnp
isol
vrnp
purifi
virion
purifi
baculovirusexpress
histag
human
gibbon
figur
protein
incub
vrnp
afterward
analyz
glycerol
gradient
centrifug
obtain
total
vrnp
protein
glycerol
gradient
fraction
ml
precipit
trichloroacet
acid
tca
precipit
dissolv
small
volum
ml
sdscontain
buffer
analyz
immunoblot
presenc
np
human
gibbon
comigr
vrnp
detect
np
immunoblot
figur
demonstr
protein
bind
hr
postinfect
viru
product
measur
plaqu
assay
error
bar
repres
standard
error
three
independ
experi
data
pass
oneway
anova
comparison
p
b
minigenom
assay
conduct
cell
lack
rigi
gene
use
plasmid
express
either
human
gibbon
contain
ring
mutat
inactiv
ligas
activ
influenza
polymeras
compon
np
pa
use
assay
udorn
viru
fireflyrenilla
luciferas
ratio
sampl
present
rel
empti
vector
control
error
bar
indic
standard
error
three
independ
replic
whole
cell
extract
prepar
addit
replic
immunoblot
antiflag
antinp
antibactin
antibodi
signific
sampl
receiv
plasmid
sampl
receiv
microgram
plasmid
calcul
use
twotail
unpair
student
ttest
p
c
minigenom
assay
conduct
rigi
knockout
cell
use
plasmid
express
ligasedefici
human
gibbon
indic
plasmid
express
wt
protein
mutant
protein
sampl
normal
vector
sampl
error
bar
repres
standard
error
three
independ
experi
whole
cell
extract
prepar
addit
replic
immunoblot
indic
antibodi
signific
human
sampl
gibbon
sampl
calcul
use
oneway
anova
p
coupl
posthoc
tukeykram
test
asterisk
indic
signific
tukeykram
test
p
see
also
figur
vrnp
differ
amount
free
observ
top
glycerol
gradient
transcript
viral
rna
replic
catalyz
polymeras
influenza
vrnp
take
place
nucleu
infect
cell
herz
et
al
predomin
found
cytoplasm
two
recent
studi
found
signific
amount
locat
nucleu
choudhuri
et
al
zhang
et
al
assess
valid
recent
studi
fraction
cell
cytoplasm
nuclear
fraction
use
recent
develop
procedur
zhao
et
al
procedur
yield
cytoplasm
fraction
contain
cytoplasm
bactin
protein
lack
nuclear
protein
nuclear
fraction
contain
lack
bactin
figur
found
cytoplasm
nucleu
wtand
rigiknockout
cell
quantit
rel
amount
cytoplasm
nuclear
measur
band
intens
take
account
volum
lysi
buffer
use
cytoplasm
nuclear
extract
amount
nucleu
approxim
amount
cytoplasm
wt
cell
approxim
amount
rigi
knockout
cell
detect
differ
local
result
udorn
viru
infect
figur
verifi
cell
fraction
result
carri
live
imag
experi
purpos
gener
doubleknockout
cell
stabli
express
gfptag
human
gibbon
live
imag
cell
show
foci
present
nuclei
movi
vitro
nucleu
virusinfect
cell
purifi
baculovirusexpress
histag
human
gibbon
incub
alon
purifi
influenza
vrnp
follow
centrifug
glycerol
gradient
immunoblot
probe
antihi
antinp
antibodi
identifi
highmolecularweight
gradient
fraction
contain
vrnp
b
fraction
wt
rigi
knockout
drigi
cell
whole
cell
extract
w
cytoplasm
extract
c
nuclear
extract
n
mockor
udorninfect
cell
immunoblot
antinp
antibactin
cytoplasm
marker
nuclear
marker
antibodi
c
coimmunoprecipit
use
antibodi
endogen
np
nuclear
extract
udorninfect
rigi
knockout
cell
mous
igg
use
control
immunoprecipit
antibodi
immunoblot
b
data
repres
two
experiment
replic
see
also
figur
movi
determin
whether
nuclear
associ
vrnp
nuclear
extract
virusinfect
rigi
knockout
cell
immunoprecipit
antibodyrecogn
endogen
np
recov
figur
result
show
associ
nuclear
vrnp
immunoprecipit
pull
individu
compon
vrnp
cotransfect
experimentsi
np
viral
polymeras
protein
figur
respons
inhibit
viral
rna
synthesi
viru
replic
rigi
knockout
cell
figur
conclud
endogen
caus
inhibit
bind
nuclear
vrnp
vrnp
catalyz
viral
rna
synthesi
infect
cell
herz
et
al
mechan
inhibit
endogen
mirror
mechan
inhibit
viral
rna
synthesi
vitro
use
purifi
vrnp
protein
describ
figur
determin
whether
bind
influenza
vrnp
rnadepend
one
mixtur
human
see
star
method
vrnp
first
treat
rnase
remov
viral
rna
vrnp
glycerol
gradient
analysi
mixtur
compar
duplic
mixtur
treat
rnase
viral
rna
outsid
surfac
influenza
vrnp
ye
et
al
suscept
rnase
digest
duesberg
ye
et
al
rnase
digest
result
nucleoprotein
complex
lower
molecular
weight
vrnp
rnasetr
figur
nonetheless
nucleoprotein
complex
fall
apart
previous
shown
other
duesberg
ye
et
al
bind
rnafre
oligomer
nucleoprotein
complex
demonstr
bind
vrnp
depend
presenc
viral
rna
vrnp
variabl
amount
free
observ
top
gradient
also
confirm
rnase
depend
bind
vrnp
context
minigenom
condit
rigi
knockout
cell
transfect
describ
figur
nuclear
extract
use
immunoprecipit
flagtag
figur
np
immunoprecipit
human
gibbon
wherea
np
detect
nuclear
extract
treat
rnase
figur
surpris
bind
influenza
vrnp
rnadepend
previou
result
establish
rnabind
activ
choudhuri
et
al
kwon
et
al
manokaran
et
al
fact
bind
influenza
virion
rna
vrna
complementari
rna
crna
detect
differ
bind
influenza
vrna
crna
gibbon
human
protein
figur
identifi
site
vrnp
human
gibbon
bind
hishuman
hisgibbon
hissumo
control
mix
vrnp
adsorb
onto
electron
microscopi
em
grid
subsequ
incub
nintananogold
particl
bind
tag
result
complex
visual
em
figur
vrnp
seen
nativ
doublehel
conform
human
gibbon
molecul
detect
nanogold
particl
bound
vrnp
although
small
amount
nonspecif
bind
hissumo
control
bind
observ
variou
differ
locat
vrnp
preferenti
bind
site
vrnp
observ
gibbon
bound
significantli
vrnp
human
figur
addit
substanti
number
individu
vrnp
contain
multipl
gibbon
molecul
wherea
individu
vrnp
contain
multipl
human
molecul
result
show
gibbon
higher
affin
human
bind
influenza
vrnp
contrast
state
gibbon
human
similar
affin
bind
influenza
vrna
figur
indic
recogn
featur
vrnp
addit
viral
rna
surfac
like
np
structur
andor
sequenc
determin
whether
bind
vrnp
lead
inhibit
transcript
activ
vrnpassoci
viral
polymeras
carri
cappedrnaprim
viral
mrna
synthesi
purifi
viral
rnp
globin
mrna
use
sourc
cappedrna
primer
shown
figur
increas
amount
purifi
human
gibbon
inhibit
cappedrnaprim
synthesi
viral
mrna
gibbon
approxim
effect
human
inhibit
viral
mrna
synthesi
reflect
differ
bind
two
molecul
vrnp
inhibit
lead
decreas
amount
fulllength
viral
mrna
synthes
without
increas
short
rna
product
pattern
inhibit
diagnost
inhibit
initi
viral
mrna
synthesi
rather
inhibit
result
prematur
termin
rna
chain
elong
accordingli
focus
effect
initi
viral
mrna
synthesi
first
step
cappedrnaprim
viral
mrna
synthesi
cleavag
cap
rna
polymeraseassoci
endonucleas
gener
cap
rna
fragment
nucleotid
length
serv
primer
reaction
requir
particip
pa
endonucleas
domain
capbind
domain
viral
polymeras
dia
et
al
guilligay
et
al
yuan
et
al
interact
directli
tripartit
polymeras
vrnp
like
endonucleas
activ
would
inhibit
assay
endonucleas
activ
cap
rna
contain
p
cap
structur
incub
vrnp
absenc
ribonucleotid
triphosph
ntp
figur
lane
neither
gibbon
gi
human
hu
inhibit
endonucleas
activ
seen
equal
accumul
rna
primer
gener
three
lane
presenc
four
ntp
absenc
gener
cap
primer
use
produc
fulllength
viral
mrna
migrat
togeth
diffus
band
near
top
gel
use
analysi
figur
lane
human
gibbon
inhibit
synthesi
fulllength
viral
mrna
cap
primer
gibbon
potent
inhibitor
figur
lane
light
exposur
lane
dark
exposur
gel
enabl
us
discov
whether
rna
transcript
smaller
smallest
fulllength
viral
mrna
produc
detect
short
transcript
even
dark
exposur
gel
confirm
result
figur
caus
prematur
termin
elong
rna
chain
henc
like
minim
amount
fulllength
mrna
produc
presenc
result
vrnp
lack
bound
addit
found
cap
primer
decreas
extent
absenc
presenc
discuss
result
compat
mechan
viral
mrna
synthesi
elucid
recent
structur
studi
reich
et
al
te
velthui
fodor
identifi
previous
unknown
antiinfluenza
viru
activ
inhibit
protein
influenza
virus
specif
use
overexpress
human
delet
human
cell
demonstr
human
target
influenza
viru
rna
synthesi
show
protein
block
rel
size
np
grey
ball
aqua
viral
polymeras
brown
correspond
rel
molecular
weight
three
protein
subunit
polymeras
pa
make
multipl
interact
interact
shown
model
instead
main
bodi
polymeras
repres
brown
donut
entri
exit
site
use
viral
mrna
synthesi
depict
donut
hole
contain
catalyt
site
nucleotid
addit
capbind
site
pa
endonucleas
locat
one
end
main
bodi
polymeras
depict
red
purpl
ball
model
cappedrnacleavag
initi
step
ident
absenc
presenc
contrast
onset
rna
chain
elong
block
presenc
discuss
text
lower
left
panel
small
arrow
indic
np
displac
order
rna
chain
enter
polymeras
copi
model
contain
aspect
polymeras
model
shown
figur
te
velthui
fodor
inhibit
influenza
viral
rna
synthesi
inhibitori
function
independ
ligas
activ
minigenom
assay
enabl
us
show
target
influenza
vrnp
therebi
inhibit
viral
mrna
synthesi
catalyz
tripartit
viral
polymeras
associ
vrnp
inhibit
viral
rna
synthesi
occur
absenc
function
rigi
infect
cell
minigenom
assay
abl
reconstitut
inhibit
vitro
purifi
compon
definit
divorc
restrict
activ
activ
host
interferon
respons
viral
rna
replic
also
catalyz
viral
polymeras
molecul
form
rnp
contain
either
vrna
crna
te
velthui
fodor
york
et
al
therefor
propos
similar
inhibit
viral
rna
replic
would
result
bind
influenzavirusspecif
rnp
particularli
also
show
endogen
bind
vrnp
nucleu
virusinfect
cell
conclud
bind
influenzavirusspecif
rnp
respons
inhibit
viral
rna
synthesi
infect
cell
sever
trim
protein
shown
restrict
influenza
viru
exact
mechan
determin
case
di
pietro
et
al
fu
et
al
liu
et
al
block
influenza
viral
rna
synthesi
viru
replic
directli
without
need
cellular
signal
interferon
induct
pathway
use
protein
nonhuman
primat
gibbon
facilit
elucid
mechan
inhibit
influenza
viru
rna
synthesi
gibbon
potent
inhibitor
influenza
viru
rna
synthesi
human
presum
human
influenza
virus
expos
gibbon
high
antiinfluenzaviru
activ
gibbon
nonhuman
primat
protein
test
suggest
nonhuman
primat
speci
also
immun
system
direct
influenzalik
virus
known
whether
antiinfluenza
activ
play
role
regul
crossspeci
transmiss
influenza
virus
interest
issu
futur
studi
result
provid
model
mechan
inhibit
viral
mrna
synthesi
vrnpassoci
polymeras
consist
recent
structur
studi
influenza
viral
polymeras
reich
et
al
te
velthui
fodor
figur
demonstr
bind
vrnp
requir
presenc
constitu
viral
rna
vrnp
access
outsid
surfac
vrnp
arranz
et
al
ye
et
al
zheng
et
al
requir
rna
expos
outer
surfac
vrnp
would
explain
least
part
lack
inhibit
sendai
viru
viral
rna
fulli
sequest
interior
vrnp
ruigrok
et
al
gibbon
higher
affin
human
influenza
vrnp
constitu
vrna
like
recogn
featur
vrnp
addit
viral
rna
outsid
surfac
interpret
result
mean
bind
viral
rna
np
protein
within
context
vrnp
therebi
clamp
two
togeth
block
movement
viral
rna
along
vrnp
surfac
interpret
provid
explan
effect
vrnpcatalyz
mrna
synthesi
observ
underli
model
inhibit
viral
mrna
synthesi
depict
figur
show
bind
vrnp
inhibit
capdepend
endonucleas
viral
polymeras
cleav
cap
rna
gener
short
cappedrna
primer
reaction
requir
activ
capbind
domain
protein
endonucleas
domain
pa
protein
requir
two
domain
posit
specif
distanc
reich
et
al
posit
requir
multipl
interact
three
polymeras
subunit
conclud
none
three
polymeras
subunit
perturb
bind
addit
catalyt
site
protein
stabil
multipl
interact
pa
subunit
reich
et
al
wright
et
al
unlik
could
neg
impact
catalyt
site
without
disturb
pa
function
consequ
like
act
initi
step
initi
viral
mrna
synthesi
detect
prematur
termin
rna
chain
reason
propos
inhibit
onset
mrna
chain
elong
elong
viral
mrna
chain
viral
polymeras
need
pull
viral
rna
templat
time
displac
np
protein
associ
viral
rna
te
velthui
fodor
onset
elong
step
figur
howev
one
molecul
bound
vrnp
would
act
clamp
vrnpassoci
viral
rna
therebi
block
movement
viral
rna
polymeras
onset
elong
step
figur
mechan
directli
inhibit
polymeras
activ
rather
depriv
polymeras
access
viral
rna
templat
model
also
consist
em
imag
show
bind
variou
place
along
length
vrnp
preferenti
bind
site
matter
bind
would
block
movement
viral
rna
polymeras
propos
clamp
would
also
depriv
polymeras
access
vrna
crna
templat
viral
rna
replic
addit
find
short
cap
primer
elong
presenc
four
ntp
degrad
compat
current
model
mechan
viral
mrna
synthesi
reich
et
al
te
velthui
fodor
previou
result
indic
capbind
site
respons
posit
cap
rna
primer
catalyt
site
nucleotid
addit
reich
et
al
te
velthui
fodor
primer
begin
bind
end
vrna
templat
initi
step
figur
posit
complet
capbind
site
dissoci
cap
cap
rna
primer
braam
et
al
te
velthui
fodor
site
particip
gener
cap
rna
primer
result
dissoci
capbind
site
elong
cap
viral
mrna
free
exit
polymeras
onset
elong
step
figur
dissoci
would
also
allow
cap
rna
primer
elong
presenc
exit
polymeras
onset
elong
step
figur
releas
small
cappedrna
primer
lack
poli
would
suscept
degrad
nucleas
human
genom
encod
approxim
trim
ubiquitin
ligas
han
et
al
although
mani
trim
shown
possess
antivir
activ
rajsbaum
et
al
detail
mechan
known
small
number
trim
best
character
exampl
restrict
form
hexagon
net
surfac
cytoplasm
viral
capsid
utter
luban
li
et
al
provid
anoth
detail
mechan
trim
restrict
involv
bind
uniqu
viral
structur
unifi
featur
trim
famili
remain
determin
howev
sens
inhibit
macromolecular
viral
complex
influenza
vrnp
retrovir
capsid
may
emerg
common
characterist
trim
restrict
detail
method
provid
onlin
version
paper
includ
follow
inform
request
resourc
reagent
direct
fulfil
lead
contact
sara
sawyer
ssawyer
coloradoedu
mta
either
univers
colorado
boulder
univers
texa
austin
requir
acquir
virus
viral
vector
use
studi
cell
line
cell
human
embryon
kidney
atcc
mdck
cell
canin
kidney
atcc
crfk
cell
felin
kidney
atcc
cultur
dulbecco
modifi
eagl
media
sigma
cell
human
lung
carcinoma
atcc
cultur
media
corn
media
supplement
fetal
bovin
serum
sigma
mm
lglutamin
invitrogen
antibiot
corn
complet
media
c
co
sinc
cell
line
obtain
renown
intern
repositori
authent
test
mycoplasma
influenza
influenza
ud
california
viru
stock
grown
fertil
chicken
egg
viru
titer
determin
use
plaqu
assay
mdck
cell
influenza
b
viru
stock
yamagata
lineag
obtain
bei
resourc
niaid
nih
viru
titer
determin
use
plaqu
assay
mdck
cell
sendai
viru
stock
formerli
parainfluenza
viru
obtain
bei
resourc
niaid
nih
titer
use
hemagluttin
assay
virus
singlecycl
infect
assay
packag
cell
cotransfect
plasmid
encod
viral
protein
vsvg
along
transfer
vector
follow
pmdlgprre
addgen
prsvrev
addgen
addgen
prrlsincpptpgkgfpwpr
addgen
fiv
barraza
poeschla
pcmvvsvg
addgen
pginsin
gfp
barraza
poeschla
nbmlv
yamashita
emerman
pcmvvsvg
addgen
plxcg
yamashita
emerman
hr
supernat
contain
virus
harvest
filter
frozen
virus
titer
crfk
cell
measur
percent
gfpposit
cell
along
volum
gradient
viru
supernat
sumo
express
construct
gene
human
genbank
orangutan
genbank
agil
gibbon
genbank
talapoin
genbank
amplifi
cdna
librari
construct
total
mrna
human
cell
atcc
orangutan
blymphocyt
coriel
agil
gibbon
fibroblast
coriel
talapoin
fibroblast
coriel
dna
copi
mrna
gener
superscript
iii
firststrand
synthesi
system
thermo
use
oligo
dt
primer
primat
human
amplifi
primer
list
tabl
use
pcr
supermix
high
fidel
thermo
construct
taclon
invitrogen
ntermin
flag
tag
ad
pcr
tag
construct
taclon
gateway
entri
plasmid
invitrogen
lr
clonas
ii
reaction
invitrogen
use
transfer
construct
gatewayconvert
plpcx
retrovir
vector
clontech
gener
ring
mutant
sitedirect
mutagenesi
carri
use
plasmid
templat
primer
contain
appropri
mutat
tabl
sumo
gene
cerevisia
ntermin
tag
clone
emd
millipor
vector
protein
express
e
coli
immunoblot
antibodi
crfk
cell
lyse
mm
nacl
mm
trishcl
ph
mm
mgcl
mm
edta
glycerol
supplement
complet
proteas
inhibitor
roch
quantifi
protein
concentr
use
bradford
assay
thermo
mg
whole
cell
extract
resolv
use
sdspolyacrylamid
gel
run
protein
transfer
mm
nitrocellulos
membran
ge
healthcar
use
wet
transfer
apparatu
run
hr
c
membran
block
tbst
contain
nonfat
dri
milk
minut
room
temperatur
block
membran
incub
primari
antibodi
dilut
tbst
hr
room
temperatur
wash
three
time
tbst
incub
secondari
antibodi
dilut
tbst
contain
nonfat
dri
milk
minut
room
temperatur
wash
three
time
tbst
develop
use
ecl
plu
detect
reagent
ge
healthcar
influenza
polymeras
subunit
detect
use
dilut
mous
antibodi
kindli
provid
juan
ochoa
et
al
influenza
detect
use
dilut
rabbit
antibodi
gener
ud
protein
express
bacteria
kuo
et
al
goat
antibodi
major
structur
protein
ha
np
udorn
viru
kindli
provid
dr
robert
lamb
use
dilut
commerci
primari
antibodi
use
mous
antiflag
sydlab
dilut
mous
antipentahi
qiagen
dilut
mous
bd
bioscienc
dilut
mous
antirigi
emd
millipor
dilut
total
detect
rabbit
santa
cruz
dilut
phosphoryl
detect
rabbit
abcam
dilut
mous
genetex
dilut
mous
antinp
bei
resourc
dilut
mous
antibactin
santa
cruz
dilut
commerci
secondari
antibodi
use
donkey
antimous
horseradish
peroxidaseconjug
thermo
scientif
dilut
donkey
antirabbit
horseradish
peroxidaseconjug
thermo
scientif
dilut
donkey
antigoat
horseradish
peroxidaseconjug
santa
cruz
gener
retrovir
vector
transduct
gene
crfk
cell
cell
seed
concentr
cellswel
dish
cell
transfect
mg
plpcx
construct
empti
encod
trim
protein
mg
encod
mlv
gagpol
mg
pcvsvg
final
ratio
mg
dna
ml
transfect
reagent
miriu
supernat
contain
retroviru
collect
hr
pass
mm
filter
use
infect
crfk
cell
presenc
polybren
hr
medium
contain
mgml
puromycin
ad
select
transduc
cell
cell
resist
puromycin
passag
expand
least
two
week
test
express
use
immunoblot
probe
antiflag
antibodi
infect
assay
crfk
stabl
cell
line
plate
concentr
cellswel
plate
infect
fiv
nbmlv
control
cell
line
infect
two
day
postinfect
cell
fix
paraformaldehyd
minut
wash
three
time
ml
fac
buffer
dpb
supplement
fb
mm
edta
resuspend
ml
fac
buffer
analyz
flow
cytometri
express
gfp
use
bd
bioscienc
fortessa
cell
analyz
experi
carri
triplic
influenza
influenza
ud
california
viru
stock
grown
fertil
chicken
egg
viru
titer
determin
use
plaqu
assay
mdck
cell
crfk
cell
human
cell
triplic
infect
indic
pfucel
udorn
california
viru
follow
incub
c
serumfre
complet
medium
supplement
nacetyl
trypsin
measur
viru
replic
aliquot
medium
taken
indic
time
infect
viru
titer
determin
plaqu
assay
mdck
cell
measur
viral
protein
product
crfk
cell
cell
infect
indic
pfucel
udorn
california
viru
cell
collect
indic
time
infect
extract
use
lysi
buffer
mm
nacl
mm
trishcl
ph
mm
mgcl
mm
edta
glycerol
supplement
complet
proteas
inhibitor
quantifi
protein
concentr
use
bradford
assay
thermo
mg
cell
extract
analyz
immunoblot
probe
antibodi
detergenttr
udorn
viru
provid
robert
lamb
antibodi
detect
np
protein
influenza
virus
surprisingli
detect
udorn
viru
ha
also
ha
california
viru
indic
retroviru
encod
either
wt
mutant
protein
incub
hr
crfk
cell
express
human
prior
ud
infect
two
retrovirus
gener
way
describ
retrovirus
express
trim
protein
measur
viral
mrna
vrna
product
infect
crfk
cell
harvest
indic
time
infect
use
rneasi
mini
kit
qiagen
rna
ng
use
gener
cdna
use
either
oligo
dt
virusspecif
primer
tabl
superscript
iii
firststrand
synthesi
system
invitrogen
cdna
use
templat
qpcr
power
sybr
green
pcr
master
mix
appli
biosystem
virusor
hostspecif
primer
tabl
cycl
qpcr
perform
use
life
technolog
crfk
cell
experi
biorad
touch
cell
experi
realtim
pcr
detect
system
sampl
normal
glyceraldehyd
dehydrogenas
gapdh
mrna
level
gener
knockout
cell
cell
seed
dish
achiev
confluenc
follow
day
twentyfour
hr
later
cell
transfect
addgen
contain
target
sequenc
complimentari
first
exon
either
rigi
figur
see
tabl
primer
contain
guid
sequenc
fulli
confluent
cell
reseed
cm
dish
complet
dmem
media
contain
mgml
puromycin
select
cell
express
hr
later
cell
dilut
seed
well
dish
cellwel
complet
dmem
media
well
contain
singl
coloni
expand
enough
cell
avail
genom
dna
extract
sequenc
rigi
loci
use
primer
list
tabl
candid
cell
line
rigi
pcr
product
clone
ten
independ
clone
sequenc
verifi
homozyg
knockout
figur
cell
seed
cm
dish
mock
treat
infect
udorn
moi
hr
cell
approxim
confluent
time
fraction
cell
seed
dish
transfect
minigenom
compon
describ
fraction
cytoplasm
nuclear
fraction
carri
describ
previous
zhao
et
al
flow
cytometri
data
figur
collect
use
bd
bioscienc
fortessa
cell
analyz
data
analyz
use
flowjo
version
softwar
flowjo
llc
averag
standard
deviat
standard
error
calcul
use
microsft
excel
detail
regard
number
replic
error
bar
found
figur
legend
graphpad
instat
softwar
graphpad
softwar
san
diego
california
use
statist
analys
two
group
compar
statist
signific
assess
twotail
unpair
student
test
singl
measur
comparison
two
group
assess
oneway
anova
follow
tukeykram
posthoc
test
multipl
comparison
accord
current
standard
practic
pvalu
consid
statist
signific
newli
gener
sequenc
orangutan
agil
gibbon
talapoin
deposit
genbank
access
number
human
genbank
orangutan
genbank
agil
gibbon
genbank
talapoin
genbank
